‘HIV Vaccine Awareness Day 2025’ - Harnessing T Cells in the Fight Against HIV: Insights from the AELIX-003 Trial
This study explored whether combining therapeutic HIV vaccines with an immune-stimulating agent could help extend the time off antiretroviral therapy in people who began antiretroviral treatment early after acquisition of HIV.